| 000 | 01638 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514163929.0 | ||
| 264 | 0 | _c20040329 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a0167-6806 | ||
| 024 | 7 |
_a10.1023/B:BREA.0000003919.75055.e8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBossard, N | |
| 245 | 0 | 0 |
_aKeeping data continuous when analyzing the prognostic impact of a tumor marker: an example with cathepsin D in breast cancer. _h[electronic resource] |
| 260 |
_bBreast cancer research and treatment _cNov 2003 |
||
| 300 |
_a47-59 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aCathepsin D _xanalysis |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Progesterone _xanalysis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aDescotes, F | |
| 700 | 1 | _aBremond, A G | |
| 700 | 1 | _aBobin, Y | |
| 700 | 1 | _aDe Saint Hilaire, P | |
| 700 | 1 | _aGolfier, F | |
| 700 | 1 | _aAwada, A | |
| 700 | 1 | _aMathevet, P M | |
| 700 | 1 | _aBerrerd, L | |
| 700 | 1 | _aBarbier, Y | |
| 700 | 1 | _aEstève, J | |
| 773 | 0 |
_tBreast cancer research and treatment _gvol. 82 _gno. 1 _gp. 47-59 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/B:BREA.0000003919.75055.e8 _zAvailable from publisher's website |
| 999 |
_c14405028 _d14405028 |
||